Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Genomic Health, Inc.    GHDX

Delayed Quote. Delayed  - 09/23 10:00:00 pm
28.84 USD   -1.03%
09/02 UBIOME HIRES NE : Dr. Audrey Goddard Joins from Genomic Health and G..
08/31 GENOMIC HEALTH : to Present at the 2016 Wells Fargo Healthcare Confe..
08/27 GENOMIC HEALTH : State Farm Mutual Automobile Insurance Co buys $8,5..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/19/2016 09/20/2016 09/21/2016 09/22/2016 09/23/2016 Date
27.84(c) 28.23(c) 28.87(c) 29.14(c) 28.84(c) Last
88 135 101 868 173 424 125 582 402 633 Volume
+0.69% +1.40% +2.27% +0.94% -1.03% Change
More quotes
Financials ($)
Sales 2016 331 M
EBIT 2016 -17,3 M
Net income 2016 -12,6 M
Debt 2016 6,36 M
Yield 2016 -
Sales 2017 368 M
EBIT 2017 3,51 M
Net income 2017 1,88 M
Debt 2017 17,3 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017 368,33
EV / Sales2016 2,92x
EV / Sales2017 2,66x
Capitalization 962 M
More Financials
Company
Genomic Health, Inc. is a global healthcare company that provides actionable genomic information to personalize cancer treatment decisions.The company has a robust pipeline focused on developing tests to optimize the treatment of renal cell cancers, as well as additional treatment decisions in... 
More about the company
Surperformance© ratings of Genomic Health, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on GENOMIC HEALTH, INC.
09/16 GENOMIC HEALTH : Presolicitation - Genomic Health/Oncotype DXB. Breast Cancer As..
09/16 GENOMIC HEALTH : Presolicitation Notice - 65-- Genomic Health/Oncotype DX-- Brea..
09/02 UBIOME HIRES NEW VICE PRESIDENT OF R : Dr. Audrey Goddard Joins from Genomic Hea..
09/01 UBIOME HIRES NEW VICE PRESIDENT OF R : Dr. Audrey Goddard Joins from Genomic Hea..
08/31 GENOMIC HEALTH : to Present at the 2016 Wells Fargo Healthcare Conference
08/27 GENOMIC HEALTH : State Farm Mutual Automobile Insurance Co buys $8,565,480 stake..
08/16 GENOMIC HEALTH : Sources Sought - 612-17-1-111-0006 - Genomic Health
08/16 GENOMIC HEALTH : Sources Sought Notice - Q-- 612-17-1-111-0006 - Genomic Health
08/11 GENOMIC HEALTH : Reports Continued Double-Digit Growth in Announcement of Second..
08/09 GENOMIC HEALTH : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
More news
Sector news : Biotechnology & Medical Research - NEC
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- 2nd Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira
09/21DJGILEAD SCIENCES : Halts Test of Bowel Disease Treatment
09/20 Bayer raises sales targets for top-selling drugs after Monsanto deal
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
08/26 COMPANION DIAGNOSTICS (CDX) : More Drugs At A Fraction Of The Cost
08/16 INSIDERINSIGHTS.COM DAILY ROUND UP 8 : William Lyon Homes, A. Schulman, Wells Fa..
08/02 Genomic Health's (GHDX) CEO Kim Popovits on Q2 2016 Results - Earnings Call T..
08/02 Genomic Health EPS in-line, beats on revenue
08/01 Notable earnings after Tuesday?s close
Advertisement
Chart GENOMIC HEALTH, INC.
Duration : Period :
Genomic Health, Inc. Technical Analysis Chart | GHDX | US37244C1018 | 4-Traders
Full-screen chart
Technical analysis trends GENOMIC HEALTH, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 32,0 $
Spread / Average Target 11%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Kimberly J. Popovits Chairman, President & Chief Executive Officer
G. Bradley Cole Chief Operating & Financial Officer
Steven Shak Chief Scientific Officer
Paul Aldridge Chief Information Officer & Senior Vice President
Phillip G. Febbo Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GENOMIC HEALTH, INC.-18.07%962
INCYTE CORPORATION-17.95%16 728
CELLTRION, INC.--.--%11 664
LONZA GROUP AG13.18%10 059
QUINTILES TRANSNATIONA..15.66%9 453
SEATTLE GENETICS, INC.24.40%7 845
More Results